Glimepiride/pioglitazone

Synthetic cytokinin growth regulator.

Synthetic cytokinin growth regulator.

InformationKY19382 (A3051) is a potent and orally active dual inhibitor of CXXC5-DVL and GSK3β with IC50 of 19 nM and 10 nM, respectively. KY19382 activates Wnt/β-catenin signaling through inhibitory effects on both CXXC5-DVL interaction and GSK3β

InformationKY19382 (A3051) is a potent and orally active dual inhibitor of CXXC5-DVL and GSK3β with IC50 of 19 nM and 10 nM, respectively. KY19382 activates Wnt/β-catenin signaling through inhibitory effects on both CXXC5-DVL interaction and GSK3β

InformationKY19382 (A3051) is a potent and orally active dual inhibitor of CXXC5-DVL and GSK3β with IC50 of 19 nM and 10 nM, respectively. KY19382 activates Wnt/β-catenin signaling through inhibitory effects on both CXXC5-DVL interaction and GSK3β

InformationKY19382 (A3051) is a potent and orally active dual inhibitor of CXXC5-DVL and GSK3β with IC50 of 19 nM and 10 nM, respectively. KY19382 activates Wnt/β-catenin signaling through inhibitory effects on both CXXC5-DVL interaction and GSK3β

InformationKY19382 (A3051) is a potent and orally active dual inhibitor of CXXC5-DVL and GSK3β with IC50 of 19 nM and 10 nM, respectively. KY19382 activates Wnt/β-catenin signaling through inhibitory effects on both CXXC5-DVL interaction and GSK3β

A potent and selective agonist of the nuclear receptor PPAR&beta/&delta (Ki = 9 nM, EC₅₀ ~500 nM for hPPAR&beta/&delta) less effective against PPAR&alpha and PPAR&gamma, with activity at those receptors depending on cell type and

A potent and selective agonist of the nuclear receptor PPAR&beta/&delta (Ki = 9 nM, EC₅₀ ~500 nM for hPPAR&beta/&delta) less effective against PPAR&alpha and PPAR&gamma, with activity at those receptors depending on cell type and

A potent and selective agonist of the nuclear receptor PPAR&beta/&delta (Ki = 9 nM, EC₅₀ ~500 nM for hPPAR&beta/&delta) less effective against PPAR&alpha and PPAR&gamma, with activity at those receptors depending on cell type and

Application L-798106, a selective prostanoid receptor EP3 antagonist, is used in prostanoid receptor signaling studies that regulate COX-2 levels and the central excitatory effects of PGE(2) on PVN neurons. Biochem/physiol Actions L-798106 was

Application L-798106, a selective prostanoid receptor EP3 antagonist, is used in prostanoid receptor signaling studies that regulate COX-2 levels and the central excitatory effects of PGE(2) on PVN neurons. Biochem/physiol Actions L-798106 was